Trial Profile
Effectiveness and Safety of Liraglutide in Patients with Weight Regain and Persistence of Type 2 Diabetes Mellitus after Bariatric Surgery
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jul 2015
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 29 Jul 2015 New trial record
- 09 Jun 2015 Results presented at the 75th Annual Scientific Sessions of the American Diabetes Association.
- 09 Jun 2015 Primary endpoint has been met. (Change in body weight)